Published in RNA on January 01, 2000
A triple helix within a pseudoknot is a conserved and essential element of telomerase RNA. Mol Cell Biol (2007) 1.61
The retroviral RNA dimer linkage: different structures may reflect different roles. Retrovirology (2004) 1.40
Visualizing transient low-populated structures of RNA. Nature (2012) 1.36
Single-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription. Biophys J (2005) 1.26
Resolving fast and slow motions in the internal loop containing stem-loop 1 of HIV-1 that are modulated by Mg2+ binding: role in the kissing-duplex structural transition. Nucleic Acids Res (2007) 1.06
Bipartite signal for genomic RNA dimerization in Moloney murine leukemia virus. J Virol (2002) 1.05
Dissecting the protein-RNA and RNA-RNA interactions in the nucleocapsid-mediated dimerization and isomerization of HIV-1 stemloop 1. J Mol Biol (2006) 1.03
Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic Acids Res (2001) 1.02
A new NMR solution structure of the SL1 HIV-1Lai loop-loop dimer. Nucleic Acids Res (2006) 1.01
Role of stem B, loop B, and nucleotides next to the primer binding site and the kissing-loop domain in human immunodeficiency virus type 1 replication and genomic-RNA dimerization. J Virol (2001) 1.01
Understanding the isomerization of the HIV-1 dimerization initiation domain by the nucleocapsid protein. J Mol Biol (2007) 0.97
Kissing complex-mediated dimerisation of HIV-1 RNA: coupling extended duplex formation to ribozyme cleavage. Nucleic Acids Res (2003) 0.96
Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion. Nucleic Acids Res (2007) 0.95
Structural polymorphism of the HIV-1 leader region explored by computational methods. Nucleic Acids Res (2005) 0.94
Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery. J Am Chem Soc (2007) 0.92
Hepatitis C virus RNA: molecular switches mediated by long-range RNA-RNA interactions? Nucleic Acids Res (2012) 0.92
Hepatitis C virus genomic RNA dimerization is mediated via a kissing complex intermediate. RNA (2010) 0.92
HIV-2 RNA dimerization is regulated by intramolecular interactions in vitro. RNA (2007) 0.89
Nucleocapsid protein-mediated maturation of dimer initiation complex of full-length SL1 stemloop of HIV-1: sequence effects and mechanism of RNA refolding. Nucleic Acids Res (2007) 0.89
Thermodynamic and kinetic analysis of an RNA kissing interaction and its resolution into an extended duplex. Biophys J (2012) 0.88
Structure and stability of RNA/RNA kissing complex: with application to HIV dimerization initiation signal. RNA (2011) 0.88
Noncovalent probes for the investigation of structure and dynamics of protein-nucleic acid assemblies: the case of NC-mediated dimerization of genomic RNA in HIV-1. Biopolymers (2009) 0.86
A genomic selection strategy to identify accessible and dimerization blocking targets in the 5'-UTR of HIV-1 RNA. Nucleic Acids Res (2004) 0.85
In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs. RNA (2007) 0.84
Synthesis of HIV-1 Psi-site RNA sequences with site specific incorporation of the fluorescent base analog 2-aminopurine. Tetrahedron (2007) 0.84
Regulation of primate lentiviral RNA dimerization by structural entrapment. Retrovirology (2008) 0.82
NMR detection of intermolecular interaction sites in the dimeric 5'-leader of the HIV-1 genome. Proc Natl Acad Sci U S A (2016) 0.81
Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA. Sci Rep (2015) 0.78
Dissecting structural transitions in the HIV-1 dimerization initiation site RNA using 2-aminopurine fluorescence. Methods (2009) 0.77
Binding characteristics of small molecules that mimic nucleocapsid protein-induced maturation of stem-loop 1 of HIV-1 RNA. Biochemistry (2010) 0.77
Molecular determinants of HIV-1 NCp7 chaperone activity in maturation of the HIV-1 dimerization initiation site. Nucleic Acids Res (2012) 0.77
Cation-dependent cleavage of the duplex form of the subtype-B HIV-1 RNA dimerization initiation site. Nucleic Acids Res (2010) 0.76
HIV-1 DIS stem loop forms an obligatory bent kissing intermediate in the dimerization pathway. Nucleic Acids Res (2014) 0.76
NMR Studies of the Structure and Function of the HIV-1 5'-Leader. Viruses (2016) 0.75
DNA-DNA kissing complexes as a new tool for the assembly of DNA nanostructures. Nucleic Acids Res (2016) 0.75
Improved estimation of secondary structure in ribonucleic acids. Nat New Biol (1973) 46.33
Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science (1998) 4.52
Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. Proc Natl Acad Sci U S A (1994) 4.07
Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol (1993) 3.78
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci U S A (1992) 3.71
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol (1994) 3.54
A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry (1994) 3.05
Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J (1994) 2.86
Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J Virol (1997) 2.86
Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA. J Biol Chem (1994) 2.71
A loop-loop "kissing" complex is the essential part of the dimer linkage of genomic HIV-1 RNA. Proc Natl Acad Sci U S A (1996) 2.56
Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA. J Virol (1996) 2.53
A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis. J Virol (1996) 2.33
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci U S A (1996) 2.30
Dimerization of HIV-1Lai RNA at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide. J Biol Chem (1995) 2.26
Kissing-loop model of HIV-1 genome dimerization: HIV-1 RNAs can assume alternative dimeric forms, and all sequences upstream or downstream of hairpin 248-271 are dispensable for dimer formation. Biochemistry (1996) 2.13
Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1. Nucleic Acids Res (1995) 1.89
Evidence that a kissing loop structure facilitates genomic RNA dimerisation in HIV-1. J Mol Biol (1996) 1.83
Structure of the dimer initiation complex of HIV-1 genomic RNA. Nat Struct Biol (1998) 1.83
A kissing complex together with a stable dimer is involved in the HIV-1Lai RNA dimerization process in vitro. Biochemistry (1996) 1.82
NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer. J Biol Chem (1996) 1.73
Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization. J Virol (1997) 1.68
Non-canonical interactions in a kissing loop complex: the dimerization initiation site of HIV-1 genomic RNA. J Mol Biol (1997) 1.66
Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions. Nucleic Acids Res (1998) 1.55
Ultrastructure of HIV-1 genomic RNA. Virology (1997) 1.49
Variant effects of non-native kissing-loop hairpin palindromes on HIV replication and HIV RNA dimerization: role of stem-loop B in HIV replication and HIV RNA dimerization. Biochemistry (1999) 1.21
HIV-1 genome dimerization: formation kinetics and thermal stability of dimeric HIV-1Lai RNAs are not improved by the 1-232 and 296-790 regions flanking the kissing-loop domain. Biochemistry (1996) 1.18
The annealing of tRNA3Lys to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structure. J Biol Chem (1998) 1.11
Multiple regions of Harvey sarcoma virus RNA can dimerize in vitro. J Virol (1995) 1.07
Mechanisms of inhibition of in vitro dimerization of HIV type I RNA by sense and antisense oligonucleotides. J Biol Chem (1996) 1.03
Solution studies of the dimerization initiation site of HIV-1 genomic RNA. Nucleic Acids Res (1998) 1.00
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science (1987) 12.77
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science (1985) 10.71
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89
HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (1990) 9.72
Complete genome sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix K1. DNA Res (1999) 7.39
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res (1998) 6.79
Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A (1992) 4.13
Microarray fabrication with covalent attachment of DNA using bubble jet technology. Nat Biotechnol (2000) 3.38
Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science (1982) 3.37
A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut (2004) 3.35
High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature (1990) 3.28
Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity (2001) 3.27
Complete genome sequence of an aerobic thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain7. DNA Res (2001) 2.99
The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J (2001) 2.78
Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res (1992) 2.72
Nucleotide sequence of the PR-1 gene of Nicotiana tabacum. FEBS Lett (1987) 2.53
Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology (1986) 2.51
Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A (1994) 2.49
Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol (1989) 2.42
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol (1986) 2.40
Counting diabetes in the next millennium. Application of capture-recapture technology. Diabetes Care (1993) 2.33
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26
Mechanisms determining aerobic or anaerobic growth in the facultative anaerobe Salmonella typhimurium. Proc Natl Acad Sci U S A (1985) 2.25
Most compact hairpin-turn structure exerted by a short DNA fragment, d(GCGAAGC) in solution: an extraordinarily stable structure resistant to nucleases and heat. Nucleic Acids Res (1994) 2.14
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel. Ann Oncol (2009) 2.14
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J Virol (1990) 2.11
A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med (1997) 2.09
Classification and Structural Comparison of Full-Length cDNAs for Pathogenesis-Related Proteins. Plant Physiol (1987) 2.06
Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC) Hum Mol Genet (1995) 2.05
HTLV-II in patients with HTLV-I-associated myelopathy. Lancet (1991) 2.04
Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology (1988) 1.96
Levels of cyclic-AMP, cyclic-GMP and betamethasone in the aqueous humor following topical administration of betamethasone in rabbit eyes. Hiroshima J Med Sci (1983) 1.89
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc Natl Acad Sci U S A (1992) 1.89
Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation. Virology (1979) 1.85
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus. Antimicrob Agents Chemother (1987) 1.82
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3 (supplement). DNA Res (1998) 1.81
Wegener's granulomatosis with intracerebral granuloma and mammary manifestation. Report of a case. Arch Intern Med (1980) 1.75
Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol (2001) 1.75
Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors. Ann Oncol (2003) 1.75
Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood (1999) 1.73
Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS (1991) 1.73
Size-resolved emission rates of airborne bacteria and fungi in an occupied classroom. Indoor Air (2012) 1.69
Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci U S A (1990) 1.68
Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci (1995) 1.68
Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro. Antimicrob Agents Chemother (1986) 1.66
Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg (1998) 1.63
Hepatitis C virus RNA in saliva. Lancet (1990) 1.62
Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X. J Virol (1997) 1.61
Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer (1996) 1.61
Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18. Neurology (2004) 1.57
Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol (1998) 1.55
Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy. Ann Oncol (2009) 1.54
[Intracranial physiological calcification on computed tomography (Part 2): Calcification in the choroid plexus of the lateral ventricles]. No To Shinkei (1988) 1.53
Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher (2001) 1.52
Detection of 12 germ-line mutations in the adenomatous polyposis coli gene by polymerase chain reaction. Gastroenterology (1993) 1.49
Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol (1999) 1.48
Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res Hum Retroviruses (1989) 1.48
Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res (1990) 1.48
Probable salmonella endocarditis treated with prosthetic valve replacement: a case report. Surgery (1974) 1.48
Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J Rheumatol (2001) 1.45
Mechanisms for generating the autonomous cAMP-dependent protein kinase required for long-term facilitation in Aplysia. Neuron (1999) 1.45
Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord. Exp Neurol (2001) 1.45
Mast cells in pseudo-Kaposi's sarcoma lesions. J Eur Acad Dermatol Venereol (2001) 1.44
Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem Pharm Bull (Tokyo) (1995) 1.44
Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation. Br J Dermatol (2015) 1.44
Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein. Biochemistry (1997) 1.44
In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology (1993) 1.43
Ethanol stimulates pepsinogen release by opening a Ca2+ channel of guinea pig gastric chief cells. Gastroenterology (1991) 1.43
Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events. Virology (1985) 1.43
Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med (2001) 1.42
Phenolic Content, Antioxidant Activity, Antibacterial Activity and Phytochemical Composition of Garcinia lancifolia. Indian J Pharm Sci (2012) 1.42
Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endoscopy (2012) 1.41
Ventricular echo beats and retrograde atrioventricular nodal exits in the dog heart: multiplicity in their electrophysiologic and anatomic characteristics. J Cardiovasc Electrophysiol (2001) 1.41
Transcription factor expression and Notch-dependent regulation of neural progenitors in the adult rat spinal cord. J Neurosci (2001) 1.41
Variables related to risk of recurrence in rectal cancer without lymph node metastasis. Ann Surg Oncol (1994) 1.41
Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol (1994) 1.41
Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res (1999) 1.41
Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med (2000) 1.40
Epidemiological survey of Orientia tsutsugamushi distribution in field rodents in Saitama Prefecture, Japan, and discovery of a new type. Microbiol Immunol (2001) 1.40
Intravital laser confocal microscopy of pulmonary edema resulting from intestinal ischemia-reperfusion injury in the rat. Crit Care Med (1999) 1.40
Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans. Int Angiol (1993) 1.40
Vesicular prurigo pigmentosa cured by minocycline. J Eur Acad Dermatol Venereol (2001) 1.40
An infectious DNA clone of HIV type 1 subtype C. AIDS Res Hum Retroviruses (1999) 1.40
Assessment of transmyocardial perfusion in alligator hearts. Circulation (1997) 1.39